Nuclera has announced the addition of a new membrane protein workflow to its benchtop eProtein Discovery system. The company says this addition will allow the expression, purification and stabilisation of challenging membrane proteins, which are often key targets in therapeutic development. Using cell-free protein synthesis,… Read More
This is the latest episode of the free DDW narrated podcast, “How is mass spectrometry advancing drug discovery?”, which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Native mass spectrometry: Drug discovery’s new kid on the… Read More
Listen to this article on the DDW Podcast: By Idlir Liko, Kleitos Sokratous & Miguel Silva at OMass Therapeutics Current drug discovery methods have limited success against certain drug targets and better approaches are needed. Professor Dame Carol Robinson’s work, including her recent publication in Nature, highlights… Read More
Researchers at the Francis Crick Institute have identified a protein that helps tumours evade the immune system and, in certain types of cancers, is linked to a poorer chance of survival. The protein could become a target for future cancer treatments. A crucial part of the immune system’s response to… Read More
PerkinElmer is serving as a provider and co-developer of assays, instrument solutions and expertise for the PROXIDRUGS Consortium which is zeroing in on research for proximity drugs or PROTACs (PROteolysis Targeting Chimeras). PROTACs are a new class of drugs that take advantage of the body’s own cell protein recycling system… Read More
This exclusive podcast features Dr Hongshan Li, Applications Manager, Sartorius, discussing advances in cell and protein analysis for virology research. This episode examines virology research – what’s currently happening in the sector and how new advances in technology are helping push forward innovation and drug development. With COVID-19 playing such… Read More
